Ratings as of Monday 5 October 2026 · updated after every US close
Relative Strength
An RS rating of 95 means the stock out-performed 95% of US stocks over the past 12 months (William O'Neil's method). This page shows who leads, who is new, who is climbing or slipping, and whether the price still looks buyable.
1,892rated193leaders at 90+17new today19coasting
▲Who is rising
New in the top tiers
4 entered 95+ · 13 entered 90+
Biggest RS jumps today
RS points gained in one day
30-day climbers
often the next 90+ names
▼Who is slipping
Coasting leaders
19 of 193 rated 90+ on old gains
3-month return in the bottom 40%
Leaders losing strength
49 of 193 fell over 30 days
Biggest RS drops today
RS points lost in one day
1,892 stocks
Below 90
1,699
90–94
96
95+
97
The 90+ tier is one in ten stocks. Everything here focuses on it.
97 92 85 60 RS tiers: 95+, 90–94, 80–89, below 80
Returns strip: 1m · 3m · 6m · 9m · 12m as percentiles. Green only on the right means coasting on old gains.
Setup check: within 15% of the 52-week high, above the 50-day and the 200-day average.
Days at 90+ counts the current unbroken streak in the leaders' tier.
Leaders momentum
which way the leaders are heading over 30 daysHow each tier moved over 30 days
RS 95+97 stocks49 rising29 flat1951% up
RS 90–9496 stocks59 rising730 falling61% up
▲ Gaining fastestRS points in 30 days · now
▼ Fading fastestleaders whose RS fell most
Bar = RS points gained or lost over 30 days · line = the RS rating over those days · badge = the rating now. Click a row to open it below.
Where the leaders are
industries by number of RS 90+ stocks · click to filterIndustryshare of 90+StocksAvg
Top 10 industries · green part of the bar = RS 95+ · 32 of the 193 leaders have no industry on file
Size of the leaders
RS 90+ stocks by market capMega (>$200B)10
Large ($10–200B)70
Mid ($2–10B)113
Small (<$2B)0
Leadership is broad when mid and small caps hold most of the 90+ list, and narrow when it sits in a few mega caps. Dark green is the 95+ share.
Rankings
#CompanyTrend 30d
14ABCLAbcellera Biologics Inc. Common Shares9920d+· 0· 0-8.2%3/39698999995Pharmaceutical Preparations1d · 030d · 0
20GOSSGossamer Bio, Inc. Common Stock9916d+· 0· 0-14.9%3/39999999898Pharmaceutical Preparations1d · 030d · 0
33SYRESpyre Therapeutics, Inc. Common Stock9820d+· 0· 0-15.8%1/38372959899Pharmaceutical Preparations1d · 030d · 0
38SDGRSchrodinger, Inc. Common Stock9812d+▲ 1· 0-1.5%3/39999989184Pharmaceutical Preparations1d ▲ 130d · 0
49CORTCorcept Therapeutics Inc.9720d+· 0· 0-3.4%3/39093989876Pharmaceutical Preparations1d · 030d · 0
55ERASErasca, Inc. Common Stock9720d+· 0▼ 2-39.4%1/32813159999Pharmaceutical Preparations1d · 030d ▼ 2
77ORKAOruka Therapeutics, Inc. Common Stock9620d+· 0▼ 2-27.0%1/32957919898Pharmaceutical Preparations1d · 030d ▼ 2
95PGENPrecigen, Inc. Common Stock9520d+▼ 2▼ 1-13.8%3/39094959395Pharmaceutical Preparations1d ▼ 230d ▼ 1
110AMLXAmylyx Pharmaceuticals, Inc. Common Stock9420d+· 0▼ 4-32.5%1/3696949692Pharmaceutical Preparations1d · 030d ▼ 4
113MBXMbx Biosciences, Inc. Common Stock9420d+· 0▼ 4-19.4%1/34963939497Pharmaceutical Preparations1d · 030d ▼ 4
141AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock9211d▲ 1▲ 11-3.9%3/39586928891Pharmaceutical Preparations1d ▲ 130d ▲ 11
184KNSAKiniksa Pharmaceuticals International, Plc Class A Ordinary Shares901d▲ 1▼ 5-8.0%2/36686919392Pharmaceutical Preparations1d ▲ 130d ▼ 5
188OGNOrganon & Co.9020d+▼ 1▼ 1-0.6%3/37163969267Pharmaceutical Preparations1d ▼ 130d ▼ 1
191TNGXTango Therapeutics, Inc.9011d▼ 1· 0-32.9%1/37911539797Pharmaceutical Preparations1d ▼ 130d · 0
1–14 of 14Page 1 of 1